About NDD-OMI


Neurodegenerative diseases (NDDs) affect a substantial and growing proportion of the aging population worldwide. Despite the increasing number of clinical trials aimed at exploring novel interventions for NDD, there is a substantial heterogeneity in the selection of appropriate instruments for outcome measurement. This platform aims to comprehensively investigate the outcome measurement instruments employed in clinical trials of NDDs in past two decades.



Search an instrument

Examples: Alzheimer Cognitive Quality of life Mini-Mental State Examination